55831-75-9 Usage
Uses
Used in Pharmaceutical Industry:
(2Z,4S,4aR,5S,5aS,11aR,12aR)-2-(amino-hydroxy-methylidene)-11a-chloro-4-dimethylamino-5,10,12a-trihydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,11,12-tetrone is used as a broad-spectrum antibiotic for treating various bacterial infections due to its ability to inhibit protein synthesis in bacteria.
Used in Drug Development:
(2Z,4S,4aR,5S,5aS,11aR,12aR)-2-(amino-hydroxy-methylidene)-11a-chloro-4-dimethylamino-5,10,12a-trihydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,11,12-tetrone is used as a starting material for the development of new drugs with improved properties, such as enhanced antibacterial activity, reduced side effects, or increased bioavailability. Its unique structure and functional groups make it a promising candidate for medicinal chemistry research and the design of novel therapeutic agents.
Used in Medicinal Chemistry Research:
(2Z,4S,4aR,5S,5aS,11aR,12aR)-2-(amino-hydroxy-methylidene)-11a-chloro-4-dimethylamino-5,10,12a-trihydroxy-6-methylidene-4,4a,5,5a-tetrahydrotetracene-1,3,11,12-tetrone is used in medicinal chemistry research to study its interactions with biological targets, such as proteins and nucleic acids. This research can provide insights into its potential pharmacological activity and help guide the development of new drugs with similar structures and mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 55831-75-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,8,3 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 55831-75:
(7*5)+(6*5)+(5*8)+(4*3)+(3*1)+(2*7)+(1*5)=139
139 % 10 = 9
So 55831-75-9 is a valid CAS Registry Number.
55831-75-9Relevant academic research and scientific papers
Preparation method of doxycycline intermediate 11 α - chloromethene terramycin (by machine translation)
-
Paragraph 0026-0028; 0031-0039, (2020/07/15)
The invention relates to the technical field of veterinary drugs, in particular to a preparation method of a brascomycin intermediate 11 α - chloromethithromycin, which takes 11 α - chlorotetracycline as a raw material, dichloromethane as a solvent, 1, 1 -dichloromethyl - N, N - dimethylamine as a dehydrating agent to obtain 11 α - chloromethithromycin. By means of the preparation method, production potential safety hazards can be reduced, the product yield is high, the generated waste salt is reduced, and the equipment type requirement is reduced. (by machine translation)
